Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Ganglioneuroblastoma × Temozolomide × Clear all

Phase

Status

Recruiting 1 Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Glioblastoma 40 Glioma 14 Neuroblastoma 13 Brain Neoplasms 12 Astrocytoma 9 Rhabdomyosarcoma 8 Sarcoma, Ewing 7 Neoplasms 7 Recurrence 6 Oligodendroglioma 5 Medulloblastoma 5 Sarcoma 4 Osteosarcoma 4 Melanoma 4 Small Cell Lung Carcinoma 3 Lymphoma 3 Gliosarcoma 3 Diffuse Intrinsic Pontine Glioma 3 Wilms Tumor 2 Ovarian Neoplasms 2 Neuroendocrine Tumors 2 Neuroectodermal Tumors, Primitive 2 Neoplasm Metastasis 2 Hepatoblastoma 2 Fallopian Tube Neoplasms 2 Ependymoma 2 Colorectal Neoplasms 2 Spinal Cord Neoplasms 1 Solid Tumor 1 Rhabdoid Tumor 1

Interventions

dinutuximab 2 sargramostim 1 lorlatinib 1 etoposide phosphate 1 Vincristine 1 Topotecan 1 Thiotepa 1 Temozolomide 1 Stem Cell Transplantation 1 Specimen Handling 1 Razoxane 1 Radiation 1 Proton Therapy 1 Platinum 1 Melphalan 1 Magnetic Resonance Spectroscopy 1 Isotretinoin 1 Irinotecan 1 Doxorubicin 1 Dexrazoxane 1 Cyclophosphamide 1 Congresses as Topic 1 Colony-Stimulating Factors 1 Cisplatin 1 Carboplatin 1 Busulfan 1 Biopsy 1 3-Iodobenzylguanidine 1 1,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07375563 2026-01-29

NB-NK-2026

Federal Research Institute of Pediatric Hematology, Oncology and Immunology

Phase 3 Recruiting

Neuroblastoma, Ganglioneuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡